KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Debt Ratio (2017 - 2025)

Amneal Pharmaceuticals has reported Debt Ratio over the past 9 years, most recently at 0.7 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.7 for Q4 2025, up 2.34% from a year ago — trailing twelve months through Dec 2025 was 0.7 (up 2.34% YoY), and the annual figure for FY2025 was 0.7, up 2.34%.
  • Debt Ratio for Q4 2025 was 0.7 at Amneal Pharmaceuticals, down from 0.71 in the prior quarter.
  • Over the last five years, Debt Ratio for AMRX hit a ceiling of 0.74 in Q1 2024 and a floor of 0.01 in Q1 2021.
  • Median Debt Ratio over the past 5 years was 0.68 (2021), compared with a mean of 0.53.
  • Biggest five-year swings in Debt Ratio: crashed 95.52% in 2022 and later soared 3929.79% in 2023.
  • Amneal Pharmaceuticals' Debt Ratio stood at 0.02 in 2021, then surged by 3065.09% to 0.69 in 2022, then rose by 7.03% to 0.74 in 2023, then decreased by 7.75% to 0.68 in 2024, then increased by 2.34% to 0.7 in 2025.
  • The last three reported values for Debt Ratio were 0.7 (Q4 2025), 0.71 (Q3 2025), and 0.64 (Q2 2025) per Business Quant data.